Résultats de la recherche - Matthias T. Stephan
- Résultat(s) 1 - 14 résultats de 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers par Fan Zhang, Neha N. Parayath, Chibawanye Ene, Sirkka B. Stephan, Amanda Koehne, Michael Coon, Eric C. Holland, Matthias T. Stephan
Publié 2019Artigo -
9
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers par Howell Moffett, Michael Coon, Stefan Radtke, Sirkka B. Stephan, Laura E. McKnight, Abigail R. Lambert, Barry Stoddard, Hans‐Peter Kiem, Matthias T. Stephan
Publié 2017Artigo -
10
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers par Tyrel T. Smith, Sirkka B. Stephan, Howell Moffett, Laura E. McKnight, Weihang Ji, Diana Reiman, Emmy Bonagofski, Martin E. Wohlfahrt, Smitha P.S. Pillai, Matthias T. Stephan
Publié 2017Artigo -
11
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors par Tyrel T. Smith, Howell Moffett, Sirkka B. Stephan, Cary F. Opel, Amy Dumigan, Xiuyun Jiang, Venu G. Pillarisetty, Smitha P.S. Pillai, K. Dane Wittrup, Matthias T. Stephan
Publié 2017Artigo -
12
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses par James J. Moon, Heikyung Suh, Anna Bershteyn, Matthias T. Stephan, Haipeng Liu, Bonnie Huang, Mashaal Sohail, Samantha S. Luo, Soong Ho Um, Htet A. Khant, Jessica T Goodwin, Jenelyn Ramos, Wah Chiu, Darrell J. Irvine
Publié 2011Artigo -
13
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2 par Eric F. Zhu, S. Annie Gai, Cary F. Opel, Byron H. Kwan, Rishi Surana, Martín C. Mihm, Monique J. Kauke, Kelly D. Moynihan, Alessandro Angelini, Christina Williamson, Matthias T. Stephan, Jacob S. Kim, Michael B. Yaffe, Darrell J. Irvine, Louis M. Weiner, Glenn Dranoff, K. Dane Wittrup
Publié 2015Artigo -
14
Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes par T. Gade, Waleed Hassen, Elmer Santos, Gertrude Gunset, Aurore Saudemont, Michael Gong, Renier J. Brentjens, Xiao-Song Zhong, Matthias T. Stephan, Jolanta Stefanski, Clay Lyddane, Joseph R. Osborne, Ian M. Buchanan, Simon J. Hall, Warren D.W. Heston, Isabelle Rivière, Steven M. Larson, Jason A. Koutcher, Michel Sadelain
Publié 2005Artigo
Outils de recherche:
Sujets similaires
Immunology
Biology
Immune system
Cancer research
T cell
Medicine
Chimeric antigen receptor
Immunotherapy
Pharmacology
Antigen
Biochemistry
Biotechnology
Cancer
Drug
In vivo
Nanocarriers
Adoptive cell transfer
Cancer immunotherapy
Cell biology
Chemistry
Internal medicine
Tumor microenvironment
Cancer cell
Computational biology
Computer science
Drug delivery
Ex vivo
Gene
Genetics
Materials science